Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Stock analysts at Zacks Research reduced their Q3 2026 earnings per share estimates for shares of Gilead Sciences in a research report ...

Melissa joined Your Hometown Station in June 2011. For two years she was the field reporter for WDBJ7 Mornin', and you could never tell where Melissa was going to be next. These days she is co ...

The United States Supreme Court heard arguments Wednesday in the case of Marlean Ames, 60, of Green, who claimed she was passed over for promotion and demoted because she is a straight woman.

Jalen Green scored 25 points, Alperen Sengun added a double-double, and the Houston Rockets held on for a 100-97 victory over the visiting Milwaukee Bucks in the NBA on Tuesday. Green sank two ...

Gilead’s lenacapavir gained approval in several nations for treating the adult population with multi-drug resistant HIV in conjunction with other antiretrovirals ...

Investors with a lot of money to spend have taken a bullish stance on Gilead Sciences GILD. And retail traders should know. We noticed this today when the positions showed up on publicly available ...

But there’s a new light in this rainbow of solutions: green light. With promises of reducing inflammation and fading pesky dark spots paired with the mesmerizing effect of bathing skin in a Brat ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Medicines Agency (EMA) has validated for parallel accelerated review the company’s ...

Gilead Sciences’ seladelpar has been granted conditional marketing authorisation by the European Commission (EC) to treat patients with the rare liver disease primary biliary cholangitis (PBC). The ...

In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against other Renaissance Technologies portfolio’s top stock picks. The American quant hedge ...

Gilead Sciences Inc. GILD stock surged to a new 52-week high at $106.69 recently on its fourth quarter of 2024 earnings release. After being asleep for so many years, the stock has finally found ...